ClinicalTrials.govpublic full text
Dose-finding Study of GSK2248761 in Antiretroviral Therapy-experienced Subjects With NNRTI-resistant HIV Infection
infection, human immunodeficiency virus, raltegravir, nnrti, ritonavir, darunavir, hiv, gsk2248761, antiretroviral, hiv infection, haart, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 1030571
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.